Hangzhou
Hangzhou
Hangzhou, Zhengjiang, China4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CAR-T Combined With ASCT in the Treatment of Relapsed/Refractory Large B-cell Lymphoma With High-risk Factors. | High-risk R/R LBCL | Recruiting | Phase 2 | 2026-05-13 | NCT07538635 | |
| Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid | Nasopharyngeal Cancinoma (NPC); Radiation-induced Oral Mucositis | Recruiting | Phase 3 | 2026-05-07 | NCT07311772 | |
| Investigate the Efficacy and Safety of BRII-835 (VIR-2218) and PEG-IFNα Combination Therapy in Chronic HBV Patients | Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic hepatitis B virus infection, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 2 | 2025-09-05 | NCT05970289 | |
| Study of HRS-1167 as Monotherapy in Patients With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 | 2025-04-15 | NCT05473624 |